Full Access
Side effects of stimulant use
F. LEVY,
Corresponding Author
F. LEVY
Avoca Clinic, Prince of Wales Children's Hospital, Randwick, New South Wales, Australia
Dr F. Levy, Avoca Clinic, Prince of Wales Children's Hospital, Randwick, NSW 2031, Australia.Search for more papers by this authorF. LEVY,
Corresponding Author
F. LEVY
Avoca Clinic, Prince of Wales Children's Hospital, Randwick, New South Wales, Australia
Dr F. Levy, Avoca Clinic, Prince of Wales Children's Hospital, Randwick, NSW 2031, Australia.Search for more papers by this authorAbstract
The current literature on side effects of central nervous system (CNS) stimulant medications used in the treatment of attention deficit hyperactivity disorder (ADHD) is reviewed, with particular emphasis on dose-response effects on differing behavioural systems. The reasons for variation in findings may lie in individual differences in children, or in differing responses of target behavioural systems. These may be understood in terms of underlying pharmacological mechanisms. Social, educational and philosophical issues relating to medication use are discussed, and the need for ongoing critical clinical and research approaches, rather than polarization of professional attitudes, is emphasized.
References
- 1 Bradley C. The behaviour of children receiving benzedrene. Am. J. Psychiatry 1937; 94: 577–84.
- 2 Levy F. CNS stimulant controversies. Aust. NZ J. Psychiatry 1984; 23: 497–502.
- 3 Safer D. J., Krager J. M. A survey of medication treatment for hyperactive/inattentive students. JAMA 1988; 260: 2256–8.
- 4 Jacobvitz D., Sroufe L. A., Stewart M., Leffert N. Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: A comprehensive review. J. Am. Acad. Child Adolesc. Psychiatry 1990; 29: 677–88.
- 5 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn; Revised. American Psychiatric Association, Washington , DC . 1987.
- 6 World Health Organization. International Classification of Diseases, 9th review. World Health Authority, Geneva , Switzerland . 1990.
- 7 Taylor E., Sandberg S., Thorley G., Giles S. The Epidemiology of Childhood Hyperactivity. Institute of Psychiatry, Maudsley Monographs, Oxford University Press, London . 1991.
- 8 Schachar R. Childhood hyperactivity. J. Child Psychol. Psychiatry 1991; 32: 155–91.
- 9 Safer D., Allen R., Barr E. Depression of growth in hyperactive children on stimulant drugs. N. Engl. J. Med. 1972; 287: 217–20.
- 10
Gittelman-Klein R.,
Landa B.,
Maths J. A.,
Klein D. F.
Methylphenidate and growth in hyperactive children: A controlled withdrawal study.
Arch. Gen. Psychiat.
1988; 33: 655–64.
10.1001/archpsyc.1976.01770060003001 Google Scholar
- 11 Gittelman-Klein R., Manuzza S. Hyperactive boys almost grown up. Methylphenidate effects on ultimate height Arch. Gen. Psychiat. 1988; 45: 1127–30.
- 12 Jensen J. B., Garfinkel B. D. Neuroendocrine aspects of attention deficit hyperactivity disorder. Endocrinol. Metab. Clin. North Am. 1988; 17: 111–27.
- 13 Barkley R. A., McMurray M. B., Edelbrock C. S., Robbins K. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systemic placebo-controlled evaluation. Pediatrics 1990; 86: 184–92.
- 14 Winsberg B. G., Kupietz S. S., Sverd J. et al. Methylphenidate oral dose plasma concentrations and behavioural response in children. Psychopharmacology 1982; 76: 329–32.
- 15 Lowe T. L., Cohen D. J., Detler J., Kremanitzer M. W., Shaywitz B. A. Stimulant medications precipitate Tourette's syndrome. JAMA 1982; 247: 1729–31.
- 16 Calis K. A., Grothe D. R., Elia J. Attention Deficit Hyperactivity Disorder. Clin. Pharm. 1990; 9: 632–42.
- 17 Comings D. E., Comings B. G. A controlled study of Tourette Syndrome: I. Attention deficit disorder, learning disorders and school problems. Am. J. Hum. Genet. 1987; 41: 701–41.
- 18 Gadow K. D., Nolan E. E., Sverd J. Methylphenidate in hyperactive boys with comorbid tic disorder II. Short-term behavioural effects in school settings. J. Am. Acad. Child Adolesc. Psychiatry 1992; 31: 462–70.
- 19 Sprague R. L., Sleator E. K. Methylphenidate and hyperkinetic children: Differences in dose effects on learning and social behaviour. Science 1977; 198: 1274–6.
- 20 Pelham W. E., Bender M. E., Caddell M. A., Booth S., Moorer S. H. Methylphenidate and children with attention deficit disorder. Arch. Gen. Psychiatry 1985; 42: 948–52.
- 21 Douglas V. I., Barr R. G., Amin K., O'Neill M. E., Britten B. G. Short-term effects of methylphenidate on the cognitive, learning and academic performance of children with attention deficit disorder in the laboratory and classroom. J. Child Psychol. Psychiatry 1986; 27: 191–211.
- 22 Rapport M. D., Du Paul G. J., Stoner G., Jones G. T. Comparing classroom and clinic measures of attention deficit disorder: Differential, idiosyncratic, and dose-response effects of methylphenidate. J. Consult Clin. Psychol. 1985; 54: 334–41.
- 23 Tannock R., Schachar R. J., Carr R. P., Logan G. D. Dose-response effects of methylphenidate on academic performance and overt behaviour in hyperactive children. Paediatrics. 1989; 84: 648–57.
- 24 Solanto M. V., Wender E. N. Does methylphenidate constrict cognitive functioning? J. Am. Acad. Child Adolesc. Psychiatry 1989; 28: 897–902.
- 25 Kupietz S. S., Winsberg B. G., Richardson E., Maitinsky S., Mendell N. Affects of methylphenidate dosage in hyperactive reading-disabled children: I: Behaviour and cognitive performance effects. J. Am. Acad. Child Adolesc. Psychiatry 1988; 27: 70–7.
- 26 Barkley R. A., De Paul G. J., McMurray M. B. Attention deficit disorder with and without hyperactivity: Clinical response to three dose levels of methyphenidate. Pediatrics 1991; 87: 519–31.
- 27 Buhrmester D., Whalen C. K., Hensler B., McDonald V., Hinshaw S. P. Prosocial behaviour in hyperactive boys: Affects of stimulant medication and comparison with normal boys. J. Abnorm. Child Psychol. 1992; 20: 103–21.
- 28 Iversen S. D., Koob G. F. Behavioural implications of dopaminergic neurons in the mesolimbic system. In E. Costa, P. Greengard eds. Advances in Biochemical Psychopharmacology, Vol. 16. Raven Press, New York , 1977; 209–14.
- 29 Jenner P., Boyce S., Marsden C. D. Effects of repeated L-DOPA administration on striatal dopamine receptor function in the rat. In S. Fahn, C. D. Marsden, P. Jenner, P. Teychenne eds. Recent Developments in Parkinson's Disease. Raven Press, New York . 1986.
- 30 Klawans H. L., Goetz C., Nausieda P. A., Weiner W. J. Levodopa-induced dopamine receptor hyper-sensitivity. Arch. Neurol. 1977; 2: 125–9.
- 31 Jenner P., Boyce S., Marsden C. D. Effects of repeated L-DOPA administration on striatal dopamine receptor function in the rat. In S. Fahn, C. Marsden, P. Jenner eds. Recent Developments in Parkinsons Disease. Raven Press, New York . 1986; 189–203.
- 32 Ridley R. M., Baker H. F. Is there a relationship between social isolation, cognitive inflexibility and behavioural stereotypy? An analysis of the effects of amphetamine in the marmoset. In K. A. Miczek ed. Ethopharmacology: Primate Models of Neuropsychiatric Disorders. Alan R. Liss Inc., New York . 1983.
- 33 Ridley R. M., Baker H. F., Haystead T. A. J. Perseverative behaviour after amphetamine: Association of response tendency from reward association. Psychopharmacology 1981; 75: 283–6.
- 34 Gray J. A., Feldon J., Rawlins J. N. P., Hemsley D. R., Smith A. D. The neuropsychology of schizophrenia. Behav. Brain Sci. 1991; 14: 1–84.
- 35 Connell P. H. Amphetamine Psychosis. Maudsley Monograph no. 5. Chapman and Hall, London . 1958.
- 36 Kalant O. J. The amphetamines: Toxicity and addiction. Brookside Monograph No. 5. University of Toronto Press, Toronto . 1966.
- 37 Angrist B., Rotrosen J., Gershon S. Differential effects of amphetamine and neuroleptics on negative versus positive symptoms in schizophrenia. Psychopharmacology 1980; 72: 17–19.
- 38 Lahey B., Schaughency E. A., Hynd G., Carlson C. L., Nieves N. Attention deficit disorder with and without hyperactivity: Comparison of behavioural characteristics of clinic-referred children. J. Am. Acad. Child Adolesc. Psychiatry 1987; 26: 718–23.
- 39 Shaywitz S. E., Shaywitz B. A. Critical issues in attention deficit disorder. In T. Sagvolden, T. Archer eds. Attention Deficit Disorder. Clinical and Basic Research. Lawrence Erlbaum Associates, New Jersey and London . 1939; 53–69.
Citing Literature
